Traws Pharma, Inc. Common Stock (TRAW) Stock Price

TRAWStock

$0.58−60.28%52W

Market Cap$8.90M

P/E0.96x

PEG Ratio—

Div yield—

Beta1.52

TRAW Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-82.82%

Price vs S&P 500 (4W)6.11%

VGM Score65.10

P/E Ratio (Annual)0.96x

Book Value / Share (Quarterly)$0.64

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)131.12%

Cash Flow / Share (Quarterly)$-1.51

Price vs S&P 500 (YTD)-62.40%

Net Profit Margin (TTM)-616.78%

EPS (TTM)$-2.07

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-2.07

EPS (Annual)$1.09

ROI (Annual)-177.55%

Net Profit Margin (5Y Avg)-19456.21%

Cash / Share (Quarterly)$0.31

P/E Basic Excl Extra (TTM)2.49x

P/E Normalized (Annual)0.96x

ROA (Last FY)86.37%

Revenue Growth TTM (YoY)1103.96%

EBITD / Share (TTM)$-2.27

Operating Margin (TTM)-698.31%

Cash Flow / Share (Annual)$-2.01

P/B Ratio1.94x

P/B Ratio (Quarterly)2.90x

Net Income / Employee (Annual)$1,310,000

EV / Revenue (TTM)1.96x

ROA (TTM)-165.91%

EV / EBITDA (TTM)2.12x

EPS Incl Extra (Annual)$1.09

Current Ratio (Annual)0.72x

Quick Ratio (Quarterly)0.38x

3-Month Avg Trading Volume1.66M

52-Week Price Return-60.28%

P/E Incl Extra (TTM)2.49x

Revenue / Employee (TTM)$390,400

Tangible BV / Share (Quarterly)$0.28

P/S Ratio (Annual)3.16x

Asset Turnover (Annual)0.26x

52-Week High$3.27

Operating Margin (5Y Avg)-17720.62%

EPS Excl Extra (Annual)$1.09

26-Week Price Return-71.57%

Quick Ratio (Annual)0.69x

13-Week Price Return-62.42%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.43x

Enterprise Value$5.69M

Asset Turnover (TTM)0.17x

Revenue / Employee (Annual)$398,600

Pretax Margin (Annual)328.67%

Cash / Share (Annual)$0.42

3-Month Return Std Dev118.64%

Net Income / Employee (TTM)$-2,775,300

ROE (Last FY)-177.55%

EPS Basic Excl Extra (Annual)$1.09

Receivables Turnover (TTM)1.64x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.07

Receivables Turnover (Annual)1.00x

ROI (TTM)265.00%

P/S Ratio (TTM)3.04x

Pretax Margin (5Y Avg)-19456.21%

Revenue / Share (Annual)$0.33

Forward P/E2.54x

Price vs S&P 500 (52W)-78.59%

P/E Ratio (TTM)2.49x

Year-to-Date Return-50.44%

5-Day Price Return3.70%

EPS Normalized (Annual)$1.09

ROA (5Y Avg)-148.31%

Net Profit Margin (Annual)328.67%

Month-to-Date Return24.44%

EBITD / Share (Annual)$-2.13

Operating Margin (Annual)-640.68%

P/E Excl Extra (TTM)2.49x

EPS Basic Excl Extra (TTM)$-2.07

P/TBV (Quarterly)6.68x

Pretax Margin (TTM)-616.78%

Price vs S&P 500 (13W)-65.21%

Beta1.52x

Revenue / Share (TTM)$0.26

ROE (TTM)265.00%

52-Week Low$0.43

vGradeB

gGradeA

mGradeD

vgmGradeB

TRAW Earnings Surprise History

Q3 25-0.34est. —

Q4 25-0.55est. -0.54

Q1 26-0.52est. -0.56

Q2 26-0.18est. -0.45

TRAW Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.25

2.29

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
TRAWTraws Pharma, Inc. Common Stock	B	A	D	$0.58
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Traws Pharma, Inc. Common Stock

Traws Pharma is a clinical-stage biopharmaceutical company developing antiviral therapies for respiratory viral diseases, with a focus on resistant strains. The company is advancing three product candidates: Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.